Publication of Clinical Data
Whether all clinical data should be made public is complicated and controversial and poses crucial ethical, legal, and practical concerns. On the one hand, there are strong reasons to make clinical data public. Sharing clinical data can speed up scientific development, increase transparency, and allow people to make better-informed healthcare decisions. On the other hand, essential privacy, confidentiality, and security considerations must be addressed. There is also a risk that making all clinical data available will lead to misuse or misinterpretation.
Clinical trials and observational studies are examples of public patient data used to enhance care and healthcare needs. To ensure that all parties are protected, protocols and laws have been set to safeguard all parties involved in trials. Congress has created rules to protect study participants based on many years of experience and learning. Every clinical investigator is now obligated to monitor and ensure the safety of every participant. These precautions are essential to the research (National Institute on Aging, 2017).
Another example of public patient data being used to enhance care is The Centers for Cancer Genomics (CCG). Recognizing cancer genomics’ promise, the National Cancer Institute (NCI) established the Center for Cancer Genomics (CCG). After CCG researchers have released a first overview and study of the data, the data is typically made available to the public. The Genomic Data Commons (GDC) hosts most of the genomics data generated by CCG initiatives. (National Cancer Institute, n.d.).
When appropriately anonymized and combined, public patient data can be an excellent resource for improving treatment nationwide. It allows academics, healthcare providers, and politicians to detect patterns, develop targeted treatments, and drive evidence-based decision-making to improve overall care quality and public health.
References
National Cancer Institute. (n.d.). About The Center for Cancer Genomics (CCG). https://www.cancer.gov/ccg/about
National Institute on Aging. (2017, May 17). Clinical Trials: Benefits, Risks, and Safety. https://www.nia.nih.gov/health/clinical-trials-benefits-risks-and-safety
ORDER A PLAGIARISM-FREE PAPER HERE
We’ll write everything from scratch
Question 
Should all clinical data be made available to the public?
Publication of Clinical Data
Why or why not? Research and provide examples of how patient data that has been made public has been used. Defend your answer by citing 2 to 3 reputable sources.
Complete the 
Complete the order payment after filling in the order form. We’ll receive your order and assign it to a writer.
The assigned writer will complete your paper and forward it to our Editing Team for review and approval.
Once approved by the editor, the completed paper will be uploaded to your account for you to download, review and approve.